trending Market Intelligence /marketintelligence/en/news-insights/trending/ArdrUpAyPGZioTXj88RdiA2 content esgSubNav
In This List

Aerie Pharmaceuticals closes stock offering

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Aerie Pharmaceuticals closes stock offering

Aerie Pharmaceuticals Inc. closed an underwritten public offering of 1,395,349 common shares at $53.75 apiece for net proceeds of about $72.4 million.

The company also sold 906,858 common shares via an at-the-market program for another $50 million.

Cantor Fitzgerald & Co. acted as the sole book runner for both transactions.